Cardiovascular aspects of menopausal hormone replacement therapy

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 41-46

  Rosano, G M C ^a   Vitale, C ^a   Fini, M ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

CARDIOVASCULAR; ENDOTHELIAL FUNCTION; ESTROGEN; HORMONE REPLACEMENT THERAPY; MENOPAUSE; PROGNOSIS

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DRUG EFFECT; ESTROGEN THERAPY; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MENOPAUSAL SYNDROME; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; AGE; AGED; CARDIOVASCULAR DISEASE; FEMALE; MIDDLE AGED; PATIENT SELECTION; PHYSIOLOGY; REVIEW; RISK ASSESSMENT; WOMEN'S HEALTH;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT SELECTION; POSTMENOPAUSE; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 73949155273     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130903012306     Document Type: Article

References (41)

1. Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-10 (Pubitemid 17052498)
3. Rosano GM, Fini M. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy. Cardiol Rev 2002;10:51-60 (Pubitemid 34130770)
4. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63
5. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210
6. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954-63
7. McFarland KF, Boniface ME, Hornung CA, Earnhardt W, Humphries JO. Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Am Heart J 1989;117:1209-14 (Pubitemid 19150748)
8. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769-75
9. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75-8
10. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9 (Pubitemid 17081015)
11. The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208
12. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11 (Pubitemid 29266405)
13. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
14. Gambacciani M, Ciapponi M, Cappagli B, Canussi B, De Simone L, Genazzani AR. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999;2:37-44 (Pubitemid 29253924)
15. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-11 (Pubitemid 36724404)
16. Rosano GM, Vitale C, Silvestri A, Fini M. The metabolic syndrome in women: implications for therapy. Int J Clin Pract Suppl 2004;139:20-5 (Pubitemid 38529518)
17. Vitale C, Mercuro G, Cornoldi A, Fini M, Volterrani M, Rosano GM. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med 2005;258:250-6 (Pubitemid 41243057)
18. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50 (Pubitemid 32378388)
19. Assmann G, Schulte H, The importance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. Eur J Epidemiol 1992;8;(Suppl 1):99-103
20. De Aloysio D, Gambacciani M, Meschia M, et al. The effect of menopause on blood lipid and lipoprotein levels. Atherosclerosis 1999;147:147-53 (Pubitemid 29486784)
21. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998;12:587-92 (Pubitemid 28458367)
22. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001;37:1199-208 (Pubitemid 34163570)
23. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-9 (Pubitemid 30650747)
24. Hsia J, Langer RD, Manson JE, et al. Women's Health Initiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-65 (Pubitemid 43244325)
25. Pansini F, Bacchi Modena AB, de Aloysio D, et al. ICARUS Study Group. Sociodemographic and clinical factors associated with HRT use in women attending menopause clinics in Italy. Climacteric 2000;3:241-7 (Pubitemid 32165441)
26. Gambacciani M, Rosano GM, Monteleone P, Fini M, Genazzani AR. Clinical relevance of the HERS trial. Lancet 2002;360:641
27. Silvestri A, Gebara O, Vitale C, et al. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation 2003;107:3165-9 (Pubitemid 36793086)
28. Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women: a randomised controlled trial. Thromb Haemost 1999;81:673-5 (Pubitemid 29216547)
29. Walsh BW, Paul S, Wild RA, et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2000;85:214-18 (Pubitemid 32268816)
30. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-19 (Pubitemid 34175253)
31. Oparil S. Hormones and vasoprotection. Hypertension 1999;33:170-6 (Pubitemid 29065655)
32. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999;43:985-91 (Pubitemid 29413198)
33. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501-10 (Pubitemid 24114224)
34. Koh KK. Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy? Int J Cardiol 2003;87:1-8 (Pubitemid 35447705)
35. Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy. Climacteric 2006;9:452-8 (Pubitemid 44691460)
36. Vitale C, Cornoldi A, Gebara O, et al. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. Menopause 2005;12:552-8 (Pubitemid 41362079)
37. Vitale C, Mercuro G, Cerquetani E, et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008;28:348-52 (Pubitemid 351161210)
38. Maffei S, Mercuri A, Zucchelli GC, Vassalle C. Estrogen therapy effects on different vasoactive factors in recent postmenopau-sal healthy women. Int J Cardiol 2006;107:194-9 (Pubitemid 43075232)
39. Herrington DM. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Intern Med 1999;131:463-6
40. Jonas HA, Kronmal RA, Psaty BM, et al. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study. Ann Epidemiol 1996;6:314-23 (Pubitemid 26299023)
41. Wassertheil-Smoller S, Anderson G, Psaty BM, et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 2000;36:780-9